Fundraising Fox
/Companies
Sign in

Metri Bio

5 known investors

Find your way into Metri Bio

Sign up to see every warm intro you have to Metri Bio

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Metri Bio team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

Metri is a biotech company developing first-in-class, disease-modifying therapeutics for endometriosis and other uterine diseases originating in the endometrium. It is building a platform to identify reliable disease targets for conditions that currently lack targeted treatments.

BiotechFemTechHealthtech

Founders & leadership

AAAshley Abel
Ashley AbelChief Executive Officer, Co-FounderAshley Abel holds a Ph.D. in Genetics from Yale University, where she conducted research on 3D stem cell models in Prof. Berna Sozen's lab, and previously earned a B.S. in Cell and Molecular Biology from Seattle University with research experience in stem cell biology at the University of Washington and Brown University. She is CEO and co-founder of Metri Bio, a biotech company developing therapeutics for endometriosis and uterine diseases.30 Under 30 2026
BSBerna Sozen, PhD
Berna Sozen, PhDAcademic Co-Founder & SAB Chair

Investors · 5

Pace Ventureslisted by Pace VenturesBerlin · $550K – $1.6Mvia Marius Swart · inferred

How we know: funding news · femtechinsider.com · Not right? Tell us

Pillar VClisted by Pillar VCBoston · $50K – $4M

How we know: Pillar VC's portfolio page · funding news · femtechinsider.com · Not right? Tell us

Also in the syndicate · 2

Navec InvestmentsSlocum Management

Funding

SEC filings, press & company announcements

$10M disclosed across 2 rounds · 2025

Source: company announcements and press reports — follow each round's link for the claim.

In the news

Metri Bio Raises $5M in Pre-Seed Fundingfinsmes.com · Dec 2025Metri Bio Raises $5M Pre-Seed to Develop Endometriosis Therapeutics​ - Metri.biometri.bio · Dec 2025

Frequently asked questions

What does Metri Bio do?
Metri is a biotech company developing first-in-class, disease-modifying therapeutics for endometriosis and other uterine diseases originating in the endometrium. It is building a platform to identify reliable disease targets for conditions that currently lack targeted treatments.
Who founded Metri Bio?
Metri Bio was founded by Ashley Abel, Berna Sozen, PhD.
Who are Metri Bio's investors?
Metri Bio's investors include Fifty Years, Pace Ventures, Pillar VC.
How much funding has Metri Bio raised?
Metri Bio has disclosed $10M raised across 2 rounds.